Margaret Bradbury

This inventor holds 9 USPTO granted patents and 10 published patent applications, plus 2 CIPO patents. Top assignee: Auspex Pharmaceuticals, Inc.. Active years: 2016-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Margaret Bradbury. Retrieved from https://idiyas.com/inventor/margaret-bradbury

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 (Patent Applications = 10)

% Patents Active = 88.9

CIPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 6.4

ph-index = 5

Forward Citations = 67(Granted Patents)

Location History:

La Jolla, CA (US) (2019)
North Wales, PA (US) (2021)
Vista, CA (US) (2016 - 2023)

Company Filing History:

9 out of 76

Auspex Pharmaceuticals, Inc.

patents

Years Active: 2016-2023

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11666566 - Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 (2023-06-06),

2. 11033540 - Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 (2021-06-15),

3. 10966922 - Pharmaceutical formulations (2021-04-06),

4. 10166183 - Pharmaceutical formulations (2019-01-01),

5. 9814708 - Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 (2017-11-14),

6. 9550780 - Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 (2017-01-24),

7. 9346800 - Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 (2016-05-24),

8. 9296739 - Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 (2016-03-29),

9. 9233959 - Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 (2016-01-12),

Title: Innovations of Margaret Bradbury

Introduction

Margaret Bradbury is a prominent inventor based in Vista, California. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target the vesicular monoamine transporter 2 (VMAT2). With a total of nine patents to her name, her work has the potential to impact the treatment of chronic hyperkinetic movement disorders.

Latest Patents

Among her latest patents is a formulation and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2. This invention relates to new pharmaceutical compositions comprising benzoquinoline compounds. The methods developed aim to inhibit VMAT2 activity in a subject, providing a novel approach for treating chronic hyperkinetic movement disorders.

Career Highlights

Margaret currently works at Auspex Pharmaceuticals, Inc., where she continues to innovate in the pharmaceutical sector. Her expertise in pharmacology and drug formulation has positioned her as a key player in her field.

Collaborations

Throughout her career, Margaret has collaborated with notable colleagues, including Andreas Sommer and Chengzhi Zhang. These partnerships have enhanced her research and contributed to the advancement of her projects.

Conclusion

Margaret Bradbury's work exemplifies the impact of innovative thinking in the pharmaceutical industry. Her contributions through her patents and collaborations continue to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.